Beta-Amyloid (1-42), HFIP-Treated

HFIP-treated Aβ(1-42) is supplied after pretreatment designed to reduce pre-existing ordered aggregates and improve control over subsequent Aβ42 assembly.

• controlled Aβ42 aggregation
• oligomer and fibril formation
• amyloid assay reproducibility
• aggregation inhibitor studies

The sequence is native Aβ42, but HFIP pretreatment is part of the product identity for aggregation experiments.

1. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis